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Here, we show that oxygen and glucose deprivation (OGD) causes increased small ubiquitin-like
modifier (SUMO)-1 and SUMO-2/3 conjugation to substrate proteins in cultured hippocampal
neurones. Surprisingly, the SUMO protease SENP-1, which removes SUMO from conjugated
proteins, was also increased by OGD, suggesting that the neuronal response to OGD involves a
complex interplay between SUMOylation and deSUMOylation. Importantly, decreasing global
SUMOylation in cultured hippocampal neurones by overexpression of the catalytic domain of
SENP-1 increased neuronal vulnerability to OGD-induced cell death. Taken together, these results
suggest a neuroprotective role for neuronal SUMOylation after OGD.
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Introduction
Posttranslational protein modification by Small
Ubiquitin-like MOdifiers (SUMOs) has been postu-
lated as an important signaling pathway in the
neuronal response to stroke (Wilkinson et al, 2010).
There are three validated SUMO paralogues, SUMO-
1–3, with SUMO-2 and SUMO-3 differing in three
amino acids. SUMOylation of most proteins is
rapidly reversed by SENPs, which also process
nascent SUMO to conjugatable SUMO. There are
six SENPs (SENP-1–3 and SENP-5–7), varying in
cellular distribution, SUMO paralogue specificity,
and selectivity for SUMO maturation versus decon-
jugation. SENP-1 has a broad specificity for SUMO-1
and SUMO-2/3 and acts in both their maturation and
deconjugation (Wilkinson and Henley, 2010).
SUMOylation is dramatically increased in hibernat-
ing squirrels what led to the hypothesis that it may
protect cells from otherwise lethally low levels of
oxygen and glucose due to reduced blood flow (Lee et
al, 2007). SUMO-1 mRNA is increased by hypoxia
(Shao et al, 2004) and SUMOylation is enhanced in
several models of ischemia (Cimarosti et al, 2008;
Yang et al, 2008a,b). Hypothermia induces SUMO-2/3
conjugation, translocation to the nucleus, and mod-
ified gene expression, further suggesting a neuropro-
tective role (Loftus et al, 2009). Consistent with this,
overexpression of UBC9, the sole SUMOylating
enzyme, increased tolerance of SHSY5Y cells to
oxygen/glucose deprivation (OGD), whereas blocking
SUMOylation by expressing its dominant negative
enhanced cell death (Lee et al, 2007). Similarly,
overexpression of SUMO-1 and SUMO-2 in SHSY5Y
cells and cortical neurones increased resistance to
OGD, whereas RNAi knockdown of SUMO-1, but not
SUMO-2, increased susceptibility (Ja Lee et al, 2009).
Recently, it has been shown that SUMO-2/3 knock-
down increases vulnerability to OGD (Datwyler et al,
2011), further suggesting SUMO-2/3 conjugation as an
endogenous neuroprotective mechanism. Here, we
examine the relationship between SUMOylation,
SENP-1, and OGD-induced cell death.
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Molecular Biology
The catalytic domain (residues 351 to 644) of wild-type
and C603S mutant SENP-1 were subcloned into attenuated
Sindbis virus (Kantamneni et al, 2011). We adjusted the
titer to achieve B90% infection for biochemistry experi-
ments and B20% for confocal imaging to allow visualiza-
tion of individual neurones.
Neuronal Cultures
Hippocampal neurones were prepared from E18 Wistar rats
(Martin et al, 2007). On the second day, to inhibit glial
growth and generate cultures with <5% glia, the culture
medium composed of Neurobasal (Gibco, Paisley, UK),
horse serum 10%, B27 (Gibco) and 2mmol/L glutamine
was substituted by Neurobasal with B27 only.
Oxygen and Glucose Deprivation
At 15 days in vitro, cells in glucose-free medium saturated
with N2 were incubated at 371C in 95% N2,5 %C O 2 for
75minutes then returned to conditioned medium and
normal atmosphere for the times indicated. Oxygen and
glucose deprivation duration was based on previous
studies (Wahl et al, 2009) to elicit significant, but not
complete cell death, allowing the assessment of potential
neuroprotective strategies. Lactate dehydrogenase (LDH)
release assays confirmed that following 75minutes OGD,
there was a very substantial increase in cell death in the
OGD-treated neurones at 24hours compared with non-
OGD.
Propidium Iodide/Hoechst Assays
In all, 24hours post-OGD neurones were stained with
propidium iodide (4mg/mL) and Hoechst (2mg/mL) for
1hour before imaging. The proportion of Hoechst-positive
nuclei that were propidium iodide positive was counted
across three fields of view. For each experiment, the mean
of at least 20 images was calculated per condition.
Immunoblotting and Densitometry
Cells were lysed in Tris-HCl 50mmol/L (pH 7.5), NaCl
150mmol/L, EDTA 10mmol/L, Triton X-100 1%, sodium
dodecyl sulfate 0.1%, protease inhibitor 1%, and NEM
20mmol/L (Martin et al, 2007). Protein concentrations
were determined and the samples were boiled for 5min-
utes at 951C with 5% b-mercaptoethanol and 2% glycerol.
Proteins were resolved by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis using 4% to 20% gradient
gels and immunoblotted using rabbit polyclonal anti-
SUMO-1 (Cell Signaling, Hitchin, UK; 1:1000), anti-
SUMO-2/3 (Zymed, Paisley, UK; 1:250), anti-SENP-1
(Imgenex, San Diego, CA, USA; 1:1,000), anti-UBC9 (Santa
Cruz, Wembley, UK; 1:250), and mouse monoclonal anti-b-
actin (Sigma, Dorset, UK; 1:10,000). Blots were scanned
and analyzed using ImageJ (NIH, Bethesda, MD, USA). The
average optical density for the non-OGD neurones (control
lane) was designated as 100%. For analysis of SUMOyla-
tion, the entire lane was sampled for proteins between 25
and 250kDa.
Quantitative Reverse Transcriptase Polymerase Chain
Reaction
RNA was extracted from neurones using RNeasy kit
(Qiagen, West Sussex, UK), DNAse-treated and reverse
transcribed (Retroscript, Ambion, Warrington, UK).
SUMO-1, SUMO-2, and SENP-1 mRNAs were measured
using TaqMan (Applied Biosystems, Warrington, UK) and
normalized to 18S rRNA using multiplexing on an
Mx3000P system (Stratagene, Stockport, UK).
Data Handling
Values are expressed as mean values±s.e.m. Student’s
t-test or analysis of variance followed by Duncan’s multi-
ple-range method was applied to determine significance.
Ethics Statement
All animal experiments were performed according to the
University of Bristol, UK, and EU good practice guidelines
and regulations.
Results
Global SUMOylation by both SUMO-1 and SUMO-2/3
in hippocampal neurones increased markedly follow-
ing OGD. Increased SUMO-1 conjugation was ob-
served at 0 and 3hours (Figure 1A) and at 3 and
24hours post-OGD for SUMO-2/3 (Figure 1B). We
reasoned that the increased SUMOylation could be
due to either increased UBC9-mediated conjugation
or reduced SENP-mediated deconjugation, so we
investigated the levels of these enzymes following
OGD. Levels of UBC9 were not altered at any time
point post-OGD (Figure 1C). Unexpectedly, however,
the levels of SENP-1 were increased at all time points
post-OGD (Figure 1D). To further characterize the
post-OGD changes in protein levels, we used quanti-
tative reverse transcriptase polymerase chain reaction
to examine SUMO-1, SUMO-2, and SENP-1 mRNAs
before and immediately after OGD. We found that
these mRNAs were unaltered following OGD, suggest-
ing that the enhanced SUMOylation and SENP-1
protein levels are not attributable to increased gene
expression during OGD (Figure 1E).
Given the increased SUMOylation observed post-
OGD, we sought to determine whether this repre-
sented a neuroprotective response. Therefore, we
overexpressed green fluorescent protein (GFP)-
tagged SENP-1 catalytic domain or the inactive
SENP-1 C603S mutant before OGD to down-
regulate SUMOylation. Virally expressed SENP-1
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jugation in neurones (Figure 2A; Kantamneni et al,
2011). We next assessed cell death as a percentage
of the total number of cells, defined by Hoechst,
that also stain for propidium iodide. Consistent
with a protective role for SUMOylation, SENP-1-
mediated reduction of SUMOylation significantly
increased neuronal death compared with SENP-1
C603S post-OGD but not in control conditions
(Figure 2B).
Figure 1 Effects of oxygen and glucose deprivation (OGD) on global protein SUMOylation, UBC9, and SENP-1 levels in hippocampal
neurons. (A, B) Representative patterns of SUMO-1 and SUMO-2/3 immunoreactive bands in total cell lysates from control and
75minutes OGD-treated hippocampal neurons. (C, D) Representative UBC9 and SENP-1 blots. In all cases, the data were quantified
from separate immunoblots using cells from three to five different cultures. The results are presented as percentage of
control±s.e.m.; * indicates significant difference compared with control P<0.05. (E) The OGD-induced increase in SUMO-1 and
SUMO-2/3 conjugation and SENP-1 protein levels is not due to increased transcription. quantitative polymerase chain reaction
(qPCR) of RNA extracted from control and OGD-treated hippocampal neurons immediately after OGD (0hours) revealed no changes
in SUMO-1, SUMO-2, or SENP-1 mRNA levels. Graphs showing quantified data from duplicates of five experiments. The results are
presented as mean±s.e.m.; no significant difference compared with control P>0.05. SUMO, small ubiquitin-like modifiers.
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Global SUMOylation is increased in cortical neu-
rones subjected to OGD (Loftus et al, 2009) and
overexpression of SUMO-1 and SUMO-2 has been
reported to reduce OGD-induced neuronal death (Ja
Lee et al, 2009) whereas knockdown of SUMO-2/3
increases OGD-induced neuronal death (Datwyler
OGD-induced increase in SUMOylation and SENP-1
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SUMO-1 and SUMO-2/3 is increased in hippocam-
pal neurones following OGD and that counteracting
this through overexpression of the catalytic domain
of SENP-1 increases OGD-induced neuronal death,
suggesting that the post-OGD SUMOylation is neuro-
protective.
To investigate the mechanism of the OGD-induced
increase in SUMO-1 and SUMO-2/3 conjugation,
we assessed the levels of the SUMOylating, UBC9,
and the deSUMOylating, SENP-1, enzymes. Unex-
pectedly, SENP-1 protein levels were increased
post-OGD whereas UBC9 was not altered, although
it should be noted that these experiments do not
address possible changes in enzymatic activity.
It has been reported that both SUMO-1 and SENP-1
mRNA levels increase following OGD and
hypoxia (Shao et al, 2004; Xu et al, 2010). We did
not detect any change in mRNA levels of SUMO-1 or
SUMO-2, suggesting that the raised SUMOylation
was likely due to the conjugation of preexisting
SUMO proteins. Despite observing an increase in
SENP-1 protein, we did not observe any change in
SENP-1 mRNA, suggesting that this increase may
result from reduced SENP-1 degradation post-OGD.
It is likely that these variations are attributable
to differences in the cell types, experimental
challenges, and/or the exposure times used between
studies.
Consistent with previous studies, we observed
no free SUMO-1 but abundant free SUMO-2/3,
indicating that the levels of free SUMO proteins are
tightly regulated (Wilkinson and Henley, 2010;
Wilkinson et al, 2010). SENP-1 overexpression did
not lead to detectable levels of free SUMO-1 or
changes in levels of free SUMO-2/3 (Figure 2). We
attribute this to compensatory cellular mechanisms
that act to regulate free SUMO levels. We did,
however, observe changes in free SUMO-2/3 follow-
ing OGD (Figure 1), suggesting that ischemic
insult can compromise the mechanisms regulating
SUMO-2/3 levels.
Our results indicate different response times for
SUMO-1 and SUMO-2/3 conjugation following
stress: SUMO-1 increases immediately after and is
still increased at 3hours before returning to control
levels at 24hours, whereas SUMO-2/3 remains stable
immediately after, but is increased at 3 and 24hours
post-OGD. Many SUMO substrates can be modified
by both SUMO-1 and SUMO-2/3, and in most cases,
the functional differences are unclear (Wilkinson
and Henley, 2010). Nonetheless, the fact that SUMO-
1 and SUMO-2/3 differ in their conjugation dy-
namics in response to OGD indicates specific
regulation of these paralogues.
We demonstrate that reducing SUMOylation
through overexpression of the catalytic domain of
SENP-1 impaired neuronal survival, suggesting that
post-OGD SUMOylation is neuroprotective. At first,
the increased levels of SENP-1 post-OGD appear
inconsistent with both increased SUMOylation and
neuroprotection, and also with viral overexpression
causing deSUMOylation. It is important to note,
however, that overexpression of the SENP-1 catalytic
domain, used here as a tool to reduce SUMOylation,
bypasses normal cellular regulation, targeting to
compartments and may not display the same sub-
strate specificity as endogenous SENP-1. Thus,
overexpression of the SENP-1 catalytic domain to
reduce SUMOylation differs from the subtle but
significant increase in endogenous SENP-1 that
presumably contributes to the neuronal response to
OGD. Therefore, while our data indicate that SU-
MOylation represents a neuroprotective mechanism
post-OGD, there also appears to be a physiologically
relevant increase in SENP-1.
The role of the SENP-1 increase is unclear but it
may be involved in the maturation of precursor
SUMO proteins into conjugation-competent forms.
While post-OGD SUMO-1 or SUMO-2 mRNA did not
increase, there may be cellular reserves of pro-SUMO
proteins, which require SENP-mediated cleavage to
initiate conjugation. Thus, we propose that the OGD-
induced increase in SENP-1 may contribute to the
OGD-induced increase in SUMOylation as shown
here and by others (Shao et al, 2004). Although we
detected global increases in SUMOylation post-OGD,
the neuronal response to OGD is likely to be subject
to subtle and complex bidirectional regulation.
Indeed, it has been shown that while a global
increase in SUMOylation occurs in HeLa cells in
response to heat stress or proteasome inhibition, the
SUMOylation of some substrates remains unchanged
and of others decreases (Golebiowski et al, 2009;
Tatham et al, 2011). Thus, it seems that targeted
SENP activity is required for an appropriate response
to cellular stress. It is currently unclear how the
maturation versus deconjugation activities of SENPs
are regulated, but our findings suggest that the post-
OGD increase in SENP-1 is somehow targeted to
Figure 2 Decreasing global protein SUMOylation increases vulnerability of hippocampal neurons to oxygen and glucose deprivation
(OGD). (A) Overexpression of the GFP-tagged catalytic domain of SENP-1 wild type (WT), but not the catalytically inactive SENP-1
C603S, globally downregulates SUMO-1 (left panel) and SUMO-2/3 (middle panel) conjugation to target proteins. GFP blots show
effective viral expression (right panel) (B) Representative images showing the effects of overexpressing SENP-1 on OGD-induced cell
death. Hippocampal neurones were infected 15hours before OGD with Sindbis virus expressing either SENP-1 WT or SENP-1
C603S. After 75minutes of OGD, cells were washed, returned to normal conditioned growth medium, and incubated for a further
24hours. They were then stained with Hoechst and propidium iodide (PI), and the proportion of nuclei stained with PI was counted.
Graph showing quantified data from four separate experiments. Overexpression of SENP-1 WTsignificantly increases cellular death in
the cultures exposed to OGD. * and # indicate significant differences compared with all groups, P<0.05. SUMO, small ubiquitin-
like modifiers.
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and/or to deSUMOylate specific subsets of sub-
strates. Taken together, our results suggest that
regulation of SENP-1 has a largely unexplored, but
nonetheless critical role in the neuronal response to
ischemic stress.
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